News | January 31, 2022
Sun Pharma Q3FY22 PAT at Rs 2058.8 cr.
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
The new centre will comprise a team of 50 highly experienced specialists
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
Potassium chloride is used to prevent or to treat low blood levels of potassium
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The vaccines are currently only authorised for emergency use in the country
It meets stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for Covid-19
Subscribe To Our Newsletter & Stay Updated
